Online citations, reference lists, and bibliographies.
Please confirm you are human
(Sign Up for free to never see this)
← Back to Search

Enhancement Of Antibody Selectivity Via Bicyclic Complex Formation

J. F. Stefanick, T. Kiziltepe, Michael W Handlogten, N. Alves, B. Bilgicer
Published 2012 · Chemistry

Save to my Library
Download PDF
Analyze on Scholarcy
Share
This study describes a strategy where antibody selectivity for high antigen-density surfaces is enhanced by forming a thermodynamically stable bicyclic complex. The bicyclic complex was formed via multivalent interactions of the antibody with a synthetic trivalent mimotope at a 3:2 molar ratio. Complex formation was analyzed using dynamic light scattering and analytical ultracentrifugation, showing a hydrodynamic radius of ∼22 nm and a calculated molecular weight of 397 kDa, depicting a trimeric complex formation. The complex has high thermodynamic stability and results in a 10-fold higher binding affinity for the trivalent mimotope (Kd = 0.14 μM) compared to the monovalent mimotope (Kd = 1.4 μM). As bicyclic complexes, the antibodies showed ∼18% binding of the monomeric form to low antigen-density surfaces. At high antigen-density, antibody binding was equal whether delivered as a complex or a monomer. These results establish bicyclic complex selectivity for high antigen-density surfaces and suggest a po...
This paper references
10.1093/AJHP/60.15.1531
Monoclonal antibodies in the treatment of cancer, Part 1.
R. J. Cersosimo (2003)
10.1517/14728220802517935
Trastuzumab cardiotoxicity: biological hypotheses and clinical open issues
E. Bria (2008)
10.1021/ja9023836
A non-chromatographic method for the purification of a bivalently active monoclonal IgG antibody from biological fluids.
B. Bilgicer (2009)
10.1021/CB6003788
Selective tumor cell targeting using low-affinity, multivalent interactions.
C. Carlson (2007)
10.1016/j.chembiol.2011.06.012
Design of a heterobivalent ligand to inhibit IgE clustering on mast cells.
M. W. Handlogten (2011)
10.1021/JA067159H
A synthetic trivalent hapten that aggregates anti-2,4-DNP IgG into bicyclic trimers.
B. Bilgicer (2007)
10.1126/SCIENCE.287.5460.1960
Drug discovery: a historical perspective.
J. Drews (2000)
10.1074/JBC.M411047200
A Novel Peptide Isolated from a Phage Display Peptide Library with Trastuzumab Can Mimic Antigen Epitope of HER-2*
Beihai Jiang (2005)
10.1007/s11523-009-0112-2
Cardiac toxicity with anti-HER-2 therapies-what have we learned so far?
E. Azambuja (2009)
10.2119/2006-00082.STEVENSON
CD38 as a Therapeutic Target
G. Stevenson (2006)
10.4049/jimmunol.173.1.394
Generation of Peptide Mimics of the Epitope Recognized by Trastuzumab on the Oncogenic Protein Her-2/neu1
A. Riemer (2004)
10.1038/nbt1142
Engineered antibody fragments and the rise of single domains
P. Holliger (2005)
10.1002/ANIE.200603381
Manufacturing immunity to disease in a test tube: the magic bullet realized.
R. Lerner (2006)
10.1016/0968-0004(84)90033-1
Cyclic complexes and high avidity antibodies
R. Thompson (1984)
10.1056/NEJMP058315
Herceptin and the heart--a molecular modifier of cardiac failure.
K. Chien (2006)
10.1016/S0378-4347(98)00338-7
Use of magnetic techniques for the isolation of cells.
I. Šafařík (1999)
10.1038/NBT0905-1037
The problem with potency
C. Scott (2005)
10.1016/S1380-2933(98)00007-4
Antibody phage display technology and its applications.
H. Hoogenboom (1998)
10.1073/pnas.122249299
Conditional mutation of the ErbB2 (HER2) receptor in cardiomyocytes leads to dilated cardiomyopathy
C. Özcelik (2002)
10.1038/nrd984
Therapeutic antibodies for human diseases at the dawn of the twenty-first century
O. H. Brekke (2003)
10.1093/clinids/21.1.150
Return to the Past: The Case for Antibody-Based Therapies in Infectious Diseases
A. Casadevall (1995)
10.1021/BI00569A004
Interaction of divalent antibody with cell surface antigens.
Jacqueline A. Reynolds (1979)
10.1016/S0093-7754(01)90278-7
Cardiotoxicity in signal transduction therapeutics: erbB2 antibodies and the heart.
J. Schneider (2001)
10.4049/jimmunol.178.11.7120
Novel Engineered Trastuzumab Conformational Epitopes Demonstrate In Vitro and In Vivo Antitumor Properties against HER-2/neu1
Joan T. Garrett (2007)
10.3816/CBC.2008.S.007
Cardiac toxicity of ErbB2-targeted therapies: what do we know?
E. Perez (2008)



This paper is referenced by
10.4049/jimmunol.1301371
A Heterobivalent Ligand Inhibits Mast Cell Degranulation via Selective Inhibition of Allergen–IgE Interactions In Vivo
M. W. Handlogten (2014)
10.1021/ac300551e
Microchip device with 64-site electrode array for multiplexed immunoassay of cell surface antigens based on electrochemiluminescence resonance energy transfer.
Meisheng Wu (2012)
10.1021/ac4008286
Nonchromatographic affinity precipitation method for the purification of bivalently active pharmaceutical antibodies from biological fluids.
M. W. Handlogten (2013)
10.1039/C3SC22033H
Reversible blocking of antibodies using bivalent peptide–DNA conjugates allows protease-activatable targeting
Bmg Brian Janssen (2013)
10.1038/nchembio.1358
Inhibition of weak-affinity epitope-IgE interactions prevents mast cell degranulation.
M. W. Handlogten (2013)
10.1042/BJ20121088
Design of a heterotetravalent synthetic allergen that reflects epitope heterogeneity and IgE antibody variability to study mast cell degranulation.
M. W. Handlogten (2013)
Design of a heterobivalent inhibitor of allergy and more physiologically relevant allergy models
M. W. Handlogten (2013)
This information is current as IgE Interactions In Vivo − Allergen Degranulation via Selective Inhibition of A Heterobivalent Ligand Inhibits Mast Cell
Karen E. Pollok (2014)
10.1039/c4an00780h
Affinity-based precipitation via a bivalent peptidic hapten for the purification of monoclonal antibodies.
M. W. Handlogten (2014)
10.4049/jimmunol.1900509
Interplay between Affinity and Valency in Effector Cell Degranulation: A Model System with Polcalcin Allergens and Human Patient–Derived IgE Antibodies
Gintare Bucaite (2019)
10.1039/c8nr09431d
Dual-receptor targeted strategy in nanoparticle design achieves tumor cell selectivity through cooperativity.
J. F. Stefanick (2019)
10.1021/cb300193f
Synthetic allergen design reveals the significance of moderate affinity epitopes in mast cell degranulation.
M. W. Handlogten (2012)
Semantic Scholar Logo Some data provided by SemanticScholar